US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
BioHarvest Sciences Inc (BHSC) 銘柄情報

BioHarvest Sciences Inc (BHSC)

7.95

0.00

(0.00%)

終了 6月8日 5:00AM

BioHarvest Sciences Inc (BHSC) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

7.95

( - )

買値

7.50

売値

8.20

出来高

-

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

7.95

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 27,843

発行済株式数

22,667,843

配当利回り

PER

-6.91

1 株当たり利益 (EPS)

-0.58

歳入

35.16M

純利益

-11.44M

BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is invo... BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company is based in Vancouver, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.bioharvest.com

本社

Vancouver, Canada

設立

-

BioHarvest Sciences Inc is listed in the sector of the Canadian Securities Exchange with ticker BHSC. The last closing price for BioHarvest Sciences was $7.95. Over the last year, BioHarvest Sciences shares have traded in a share price range of $ 0.00 to $ 0.00.

BioHarvest Sciences currently has 22,667,843 shares in issue. The market capitalisation of BioHarvest Sciences is $180.21 million. BioHarvest Sciences has a price to earnings ratio (PE ratio) of -6.91.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	0	0	0	0	0	0	0	CS
156	0	0	0	0	0	0	0	CS
260	0	0	0	0	0	0	0	CS

BHSC - Frequently Asked Questions (FAQ)

What is the current BioHarvest Sciences Inc share price?

The current share price of BioHarvest Sciences Inc is $ 7.95

How many BioHarvest Sciences Inc shares are in issue?

BioHarvest Sciences Inc has 22,667,843 shares in issue

What is the market cap of BioHarvest Sciences Inc?

The market capitalisation of BioHarvest Sciences Inc is CAD 180.21M

What is the 1 year trading range for BioHarvest Sciences Inc share price?

BioHarvest Sciences Inc has traded in the range of $ 0.00 to $ 0.00 during the past year

What is the PE ratio of BioHarvest Sciences Inc?

The price to earnings ratio of BioHarvest Sciences Inc is -6.91

What is the cash to sales ratio of BioHarvest Sciences Inc?

The cash to sales ratio of BioHarvest Sciences Inc is 2.58

What is the registered address of BioHarvest Sciences Inc?

The registered address for BioHarvest Sciences Inc is 1140-625 Howe Street, Vancouver, British Columbia, V6C 2T6

What is the BioHarvest Sciences Inc website address?

The website address for BioHarvest Sciences Inc is www.bioharvest.com

LOB

You Guys need to stop comparing BCDS to NSAV ..

tisdal

I do understand that the price points made in prophetic statements are what today seems high. No timeline was given within the prophecy.
I will say this was not the only prophecy where such numbers were given.

I think what you may be more comfortable with is what JRyan uses

Myth

John Campbell - Person To Person live

https://www.youtube.com/watch?v=KpcE15tM2Eo

gdog

https://stocktwits.com/news-articles/markets/equity/netlist-bags-federal-circuit-win-rejects-micron-patent-challenge/cZRNkluR4xw

ONE OF THESE DAYS

Seminole Red

Seminole Red 6分前

conner zilch needs to go back to the O'reily series, at least he was winning there, kid cant do nothing in Cup races

tnyellowtomcat

tnyellowtomcat 6分前

Bobroo,

The IP, and trademark, held by LiquidMetasl have industrial sized potential.

- Tomcat

Jetmek_03052

Jetmek_03052 8分前

Relax.

It's not a crime to not know how to do something, and I didn't say it was. I have OFTEN said how EASY it is to sign up for things like Court Listener, Pacer and other services where people could get information about the many lawsuits and hearings that are in play for Netlis

Rhodan

randychub

randychub 9分前

PFE must be comfortable with their original argument, or they would not have chosen to stand on that ground.

Myth

John Campbell - Saddle Up My Pony live

https://www.youtube.com/watch?v=f-csuxRIZrI

100lbStriper

100lbStriper 10分前

Stokd $NLST And lastly, after covering/addressing recent developments, approaching Friday is Samsung's deadline to file the last brief in the BOC case appeal, after which the scheduling of oral argument phase begins, once a date is assigned and orals are held, we await a decision.
https://med

Major Profits

Major Profits 10分前

"Honesty has never been in a otc chat board pumpers profile or vocabulary.
Facts are poison to otc shillers."
I agree. Imo, "Pumpers" are far more likely to post DISinformation than "Bashers" are.

GL🍀

FrostyIsland3

FrostyIsland3 11分前

To recap, the MHRA will not reject the DCVax-L MAA without the CHM issuing a CHM Letter to NWBO prior to rejection. A CHM Letter is clearly material information that must be disclosed to the investing public. The fact that there has been no disclosure of such a CHM Letter is widely interpreted by

SemperFITrader

SemperFITrader 11分前

Flipper, I agree 100% based on Facts from MHRA email and reading through the lines of the GZ email.

100lbStriper

100lbStriper 12分前

Stokd $NLST Regarding the DE Samsung/Google case on the 523 patent, Friday all parties agreed and jointly stipulated to extend the stay on the case pending the ITC action, which we have covered extensively is mandatory for any patents in current parallel litigation at ITC. If parties didn't file th

100lbStriper

100lbStriper 14分前

Stokd $NLST Netlist requested Director Review in 087 PGR & 731 IPR, then Dir Squires allowed Netlist's motion for additional discovery into the RPI issue, and Netlist also asked to address Samsung’s inconsistent position in ITC. Samsung in response claimed they didn't take inconstant positions but

flipper44

flipper44 14分前

Here’s where I’m at. IMO:

1. November 24, 2025 CTBVEAG did not give advice on DCVax-l.

2. November 28, 2025 CHM committee did give advice on DCVax-l, with no negative comments in the minutes.

rosemountbomber

rosemountbomber 14分前

This ties in to what you are saying:
https://finance.yahoo.com/markets/stocks/articles/fidelity-slashed-spacex-minimum-2-171500631.html

12yearplan

12yearplan 15分前

That was just Tungsten - whole lot more global reaching "elements" in play with China and others:

Go to NIOCORP_MINE
r/NIOCORP_MINE
•
3h ago
Gman-303
The Harsh Truth About China’s Critical Mineral Stranglehold OPINION - Daily Caller - James C

100lbStriper

100lbStriper 16分前

Stokd $NLST Let’s not lose the plot and drift off narrative by amplifying something unimportant, certainly not a catalyst, and incorrectly attribute significance to its outcome — Micron ID suit & CAFC hearing on remand from ID Fed to State.

As addressed extensively over time with re

SemperFITrader

SemperFITrader 17分前

flipper, I did ask for clarification on that, he came back with "They're linked. CTBVEAG is a sub-group of the CHM and it reports directly to the CHM" So he is speaking as one in the same apparently, that is reason I did not post anything to avoid any confusion. Bottom line is the EAG has nothing

BIOChecker4

BIOChecker4 18分前

No reason to hire anybody when your job is to sell the company.

alm2

Patent litigation - Supreme Court decision
From a lawyers point of view tge litigation was interesting
From Amarins point of view maybe it was worth the lawyers fees to recover damages many years hence or a settlement payout from Hikma
It was never going to change the USA gen

Eli's Gone

Eli's Gone 21分前

flipper44

flipper44 21分前

Apparently George doesn’t know the difference between EAG and CHM, or he is needlessly conflating them.

BioHarvest Sciences

Evolve CA Banks and Life...

Nexus Infrastructure

John Hancock Multifactor...

Exchange Traded Commodity

Xtrackers IE Public

Selective Insurance

Ci Balanced Growth Asset...

Zero Cpn Instal Idx Redp...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。